Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Abstract

OBJECTIVE To assess the postprandial glucose-lowering effect of the human amylin analog pramlintide when given with either regular insulin or insulin lispro in subjects with type 1 diabetes, with an emphasis on the optimal dose timing relative to meals. RESEARCH DESIGN AND METHODS In this randomized, single-blind, placebo-controlled, five-way crossover… (More)

3 Figures and Tables

Topics

  • Presentations referencing similar topics